封面
市場調查報告書
商品編碼
1594538

核醫放射性同位素市場:按產品類型、應用和最終用戶分類 - 全球預測 2025-2030

Nuclear Medicine Radioisotopes Market by Product Type (Diagnostics, Therapeutic), Application (Gastroenterology, Neurology, Oncology), End-User - Global Forecast 2025-2030

出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

核醫放射性同位素市場2023年估值為104.6億美元,預計2024年將達119.4億美元,複合年成長率為14.50%,到2030年將達270億美元。

核醫放射性同位素是用於醫療領域診斷和治療應用的放射性物質,是 PET 和 SPECT 掃描等成像技術的重要工具。這種需求源於生物過程的詳細和非侵入性視覺化以及治療癌症、心血管疾病和神經系統疾病等疾病的潛力。最終用途主要包括醫院、診斷中心和研究機構。市場成長主要受到慢性病盛行率不斷上升、技術進步以及早期診斷意識不斷增強的影響。然而,該市場受到諸如手術成本高、監管挑戰以及需要嚴格遵守涉及放射性材料的安全通訊協定等因素的限制。鉬 99(放射性同位素生產的關鍵成分)等材料的供應鏈由於其複雜性和有限性也可能成為瓶頸。開發更有效率、更具成本效益的同位素並擴大其在腫瘤學以外的領域的應用,特別是神經病學和心臟病學,存在機會。研究機構和商業公司之間的合作夥伴關係可以透過縮小技術開發和臨床應用之間的差距來增強創新。為了利用這些機會,相關人員必須投資於新型同位素生產方法的高級研究,例如整合診斷和治療能力的標靶α療法和治療診斷學。改良的輸送系統也可能出現創新,以提高放射性同位素應用的精確度、減少副作用並提高治療效果。由於市場仍然高度競爭和細分,公司有空間透過創新解決方案和策略聯盟來應對這些關鍵挑戰並影響市場動態。市場本質上是進步的,但需要適應性策略來跟上技術進步和監管變化。

主要市場統計
基準年[2023] 104.6億美元
預測年份 [2024] 119.4億美元
預測年份 [2030] 270億美元
複合年成長率(%) 14.50%

市場動態:揭示快速發展的核醫學放射性同位素市場的關鍵市場洞察

核醫放射性同位素市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態,公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險,同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 對 SPECT、PET 掃描和核子醫學的需求不斷成長
    • 放射性藥物市場顯著成長
    • 癌症和心臟病的盛行率增加
  • 市場限制因素
    • 高輻射暴露引起的副作用
  • 市場機會
    • 放射線治療顯著成長
    • 治療診斷學在核子醫學中日益普及
  • 市場問題
    • 嚴格的政府法規

波特五力:駕馭核醫放射性同位素市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢,解決弱點,避免潛在的挑戰,確保更強大的市場地位。

PESTLE分析:了解核醫放射性同位素市場的外部影響

外部宏觀環境因素在塑造核醫放射性同位素市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素,公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化,並為他們做出積極主動的決策做好準備。

市場佔有率分析:了解核醫放射性同位素市場的競爭狀況

核醫放射性同位素市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢,為供應商提供了製定策略決策所需的洞察力,使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣:核醫放射性同位素市場供應商的績效評估

FPNV 定位矩陣是評估核醫放射性同位素市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商,從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商,並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議:規劃核醫放射性同位素市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說,對核醫學放射性同位素市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標,公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰,利用新的商機,並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1.市場滲透率:對當前市場環境的詳細審查,主要企業的廣泛資料,評估他們在市場中的影響力和整體影響力。

2. 市場開拓:辨識新興市場的成長機會,評估現有細分市場的擴張潛力,並提供未來成長的策略藍圖。

3. 市場多元化:分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報:徹底分析競爭格局,檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新:重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題,以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少?

2. 哪些產品和地區提供最佳投資機會?

3.塑造市場的關鍵技術趨勢和監管影響是什麼?

4.主要廠商的市場佔有率和競爭地位如何?

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼?

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 對 SPECT、PET 掃描和核子醫學的需求不斷成長
      • 放射性藥物顯著成長
      • 癌症和心臟病的發生率增加
    • 抑制因素
      • 高暴露會導致副作用
    • 機會
      • 放射治療顯著增加
      • 治療診斷學在核子醫學中日益普及
    • 任務
      • 嚴格的政府法規
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章核醫放射性同位素市場:依產品類型

  • 介紹
  • 診斷
    • 氟18
    • 鎵67
    • Technetium99
    • 鉈201
  • 治療
    • 碘131
    • 錸186
    • 釤153
    • 釔90

第7章核子醫學放射性同位素市場:依應用分類

  • 介紹
  • 胃腸病學
  • 神經病學
  • 腫瘤學
  • 整形外科

第8章核子醫學放射性同位素市場:依最終使用者分類

  • 介紹
  • 診斷中心
  • 教育/研究機構
  • 醫院
  • 專科診所

第9章 北美和南美核子醫學放射性同位素市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太核醫學放射性同位素市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲核子醫學放射性同位素市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣,2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Bruce Power Inc.
  • Eckert & Ziegler Strahlen-und Medizintechnik AG
  • General Atomics Electromagnetic Systems
  • Grantek Systems
  • International Isotopes Inc.
  • Medical Isotopes, Inc.
  • NorthStar Medical Radioisotopes, LLC
  • Nuclear Research and consultancy Group
  • Ontario Power Generation Inc.
  • Orano Group
  • ROSATOM State Atomic Energy Corporation
  • SHINE Technologies, LLC
  • SOFIE Co.
  • Urenco Stable Isotopes
Product Code: MRR-742BD51821D7

The Nuclear Medicine Radioisotopes Market was valued at USD 10.46 billion in 2023, expected to reach USD 11.94 billion in 2024, and is projected to grow at a CAGR of 14.50%, to USD 27.00 billion by 2030.

Nuclear medicine radioisotopes are radioactive substances used in diagnostic and therapeutic applications within the medical field, serving as vital tools for imaging techniques such as PET and SPECT scans. Their necessity arises from their capacity to provide detailed, non-invasive visualization of biological processes and treatment of conditions like cancer, cardiovascular diseases, and neurological disorders. The end-use scope primarily includes hospitals, diagnostic centers, and research institutions. Market growth is primarily influenced by the increasing prevalence of chronic diseases, technological advancements, and growing awareness regarding early diagnostics. However, the market is limited by factors such as high costs of procedures, regulatory challenges, and the need for strict compliance with safety protocols involving radioactive materials. The supply chain for materials like Molybdenum-99, a key component in radioisotope production, can also be a bottleneck due to its complex and limited nature. Opportunities lie in the development of more efficient and cost-effective isotopes and expanding applications beyond oncology, particularly in neurology and cardiology. Collaborative partnerships between research institutions and commercial enterprises can enhance innovation by bridging gaps between technology development and clinical adoption. To capitalize on these opportunities, it is essential that stakeholders invest in advanced research for novel isotope production methods, such as targeted alpha therapy and theranostics, which integrate diagnostic and therapeutic capabilities. Innovation can also emerge from improving delivery systems to enhance the precision of radioisotope applications, reducing side effects, and increasing therapeutic efficacy. While the market is competitive, it remains fragmented, providing room for entrants who can address these key challenges and influence market dynamics through innovative solutions and strategic alliances. The nature of the market is progressive but requires adaptive strategies to stay aligned with technological advancements and regulatory changes.

KEY MARKET STATISTICS
Base Year [2023] USD 10.46 billion
Estimated Year [2024] USD 11.94 billion
Forecast Year [2030] USD 27.00 billion
CAGR (%) 14.50%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Nuclear Medicine Radioisotopes Market

The Nuclear Medicine Radioisotopes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing need for SPECT, PET scan and nuclear medicine
    • Remarkable growth of radiopharmaceutical drugs
    • Increasing prevalence of cancer and cardiac disorders
  • Market Restraints
    • Side effects with higher exposure
  • Market Opportunities
    • Substantial growth of radiation therapy
    • Emerging popularity of theranostics in nuclear medicine
  • Market Challenges
    • Stringent government regulations

Porter's Five Forces: A Strategic Tool for Navigating the Nuclear Medicine Radioisotopes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Nuclear Medicine Radioisotopes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Nuclear Medicine Radioisotopes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Nuclear Medicine Radioisotopes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Nuclear Medicine Radioisotopes Market

A detailed market share analysis in the Nuclear Medicine Radioisotopes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Nuclear Medicine Radioisotopes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Nuclear Medicine Radioisotopes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Nuclear Medicine Radioisotopes Market

A strategic analysis of the Nuclear Medicine Radioisotopes Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Nuclear Medicine Radioisotopes Market, highlighting leading vendors and their innovative profiles. These include Bruce Power Inc., Eckert & Ziegler Strahlen- und Medizintechnik AG, General Atomics Electromagnetic Systems, Grantek Systems, International Isotopes Inc., Medical Isotopes, Inc., NorthStar Medical Radioisotopes, LLC, Nuclear Research and consultancy Group, Ontario Power Generation Inc., Orano Group, ROSATOM State Atomic Energy Corporation, SHINE Technologies, LLC, SOFIE Co., and Urenco Stable Isotopes.

Market Segmentation & Coverage

This research report categorizes the Nuclear Medicine Radioisotopes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Diagnostics and Therapeutic. The Diagnostics is further studied across Fluorine-18, Gallium-67, Technetium-99, and Thallium-201. The Therapeutic is further studied across Iodine-131, Rhenium-186, Samarium-153, and Yttrium-90.
  • Based on Application, market is studied across Gastroenterology, Neurology, Oncology, and Orthopedics.
  • Based on End-User, market is studied across Diagnostic Centers, Education & Research Institutes, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing need for SPECT, PET scan and nuclear medicine
      • 5.1.1.2. Remarkable growth of radiopharmaceutical drugs
      • 5.1.1.3. Increasing prevalence of cancer and cardiac disorders
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects with higher exposure
    • 5.1.3. Opportunities
      • 5.1.3.1. Substantial growth of radiation therapy
      • 5.1.3.2. Emerging popularity of theranostics in nuclear medicine
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Nuclear Medicine Radioisotopes Market, by Product Type

  • 6.1. Introduction
  • 6.2. Diagnostics
    • 6.2.1. Fluorine-18
    • 6.2.2. Gallium-67
    • 6.2.3. Technetium-99
    • 6.2.4. Thallium-201
  • 6.3. Therapeutic
    • 6.3.1. Iodine-131
    • 6.3.2. Rhenium-186
    • 6.3.3. Samarium-153
    • 6.3.4. Yttrium-90

7. Nuclear Medicine Radioisotopes Market, by Application

  • 7.1. Introduction
  • 7.2. Gastroenterology
  • 7.3. Neurology
  • 7.4. Oncology
  • 7.5. Orthopedics

8. Nuclear Medicine Radioisotopes Market, by End-User

  • 8.1. Introduction
  • 8.2. Diagnostic Centers
  • 8.3. Education & Research Institutes
  • 8.4. Hospitals
  • 8.5. Specialty Clinics

9. Americas Nuclear Medicine Radioisotopes Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Nuclear Medicine Radioisotopes Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Nuclear Medicine Radioisotopes Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Bruce Power Inc.
  • 2. Eckert & Ziegler Strahlen- und Medizintechnik AG
  • 3. General Atomics Electromagnetic Systems
  • 4. Grantek Systems
  • 5. International Isotopes Inc.
  • 6. Medical Isotopes, Inc.
  • 7. NorthStar Medical Radioisotopes, LLC
  • 8. Nuclear Research and consultancy Group
  • 9. Ontario Power Generation Inc.
  • 10. Orano Group
  • 11. ROSATOM State Atomic Energy Corporation
  • 12. SHINE Technologies, LLC
  • 13. SOFIE Co.
  • 14. Urenco Stable Isotopes

LIST OF FIGURES

  • FIGURE 1. NUCLEAR MEDICINE RADIOISOTOPES MARKET RESEARCH PROCESS
  • FIGURE 2. NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. NUCLEAR MEDICINE RADIOISOTOPES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NUCLEAR MEDICINE RADIOISOTOPES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NUCLEAR MEDICINE RADIOISOTOPES MARKET DYNAMICS
  • TABLE 7. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY FLUORINE-18, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY GALLIUM-67, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY TECHNETIUM-99, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THALLIUM-201, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY IODINE-131, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY RHENIUM-186, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY SAMARIUM-153, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY YTTRIUM-90, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY EDUCATION & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY DIAGNOSTICS, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY THERAPEUTIC, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM NUCLEAR MEDICINE RADIOISOTOPES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. NUCLEAR MEDICINE RADIOISOTOPES MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 240. NUCLEAR MEDICINE RADIOISOTOPES MARKET, FPNV POSITIONING MATRIX, 2023